There are numerous factors that affect the cost of a cervical disc replacement, and researchers used a machine learning model to analyze key variables for a stu ...
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
EPP is a rare genetic disorder that causes severe burn injuries on the skin following exposure to visible light. Credit: Cavan Images via Getty Images. Disc Medicine has raised $225.5m through an ...
WATERTOWN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery ...
Disc Medicine has finalized the design of the confirmatory trial for its rare blood disorder drug candidate, adding a co-primary endpoint at the request of the FDA to clear the path to accelerated ...
WHILE women are primed from a young age to spot suspicious signs in their breasts, they may be less well equipped when it comes to symptoms of cervical cancer. Signs of the disease - which affects ...
Disc Medicine, Inc. (NASDAQ:IRON), a biotechnology company focused on developing treatments for rare blood disorders, has made significant strides in its clinical pipeline and market position over ...
Disc Medicine, Inc. (NASDAQ:IRON), a biotechnology company focused on developing treatments for rare blood disorders, has made significant strides in its clinical pipeline and market position over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback